Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
This study has been completed.
First Received: March 13, 2003   Last Updated: November 18, 2009   History of Changes
Sponsor: Novartis
Collaborator: Bayer
Information provided by: Novartis
ClinicalTrials.gov Identifier: NCT00056459
  Purpose

To compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread to other organs and are seeking first chemotherapy treatment


Condition Intervention Phase
Colorectal Neoplasms
Colonic Neoplasms
Rectal Neoplasms
Drug: Vatalanib
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: A Randomized, Double-blind, Placebo-controlled, Phase Lll Study in Patients With Metastatic Adenocarcinoma of the Colon or Rectum Who Are Receiving First-line Chemotherapy With Oxaliplatin/5-fluorouracil/Leucovorin With PTK787/ZK 222584 or Placebo

Resource links provided by NLM:


Further study details as provided by Novartis:

Primary Outcome Measures:
  • Progression free survival [ Time Frame: Throughout duration of study ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Time to progression [ Time Frame: Throughout duration of study ] [ Designated as safety issue: No ]
  • Time to treatment failure [ Time Frame: Throughout duration of study ] [ Designated as safety issue: No ]
  • Best overall response rate [ Time Frame: Throughout duration of study ] [ Designated as safety issue: No ]
  • Tolerability and safety profile [ Time Frame: Throughout duration of study ] [ Designated as safety issue: No ]

Enrollment: 1168
Study Start Date: February 2003
Estimated Study Completion Date: May 2004
Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Oxaliplatin/5-FU/LV and PTK787/ZK 222584
Drug: Vatalanib
2: Placebo Comparator
Oxaliplatin/5-FU/LV and placebo
Drug: Vatalanib

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • Patients with metastatic colorectal cancer coming for initial chemotherapy
  • Documented metastatic colorectal cancer
  • WHO Performance Status of 0, 1, or 2
  • Measurable tumors
  • Adequate hematologic status, liver and kidney function
  • Life expectancy greater than 12 weeks
  • Written informed consent obtained

Exclusion criteria:

  • History or presence of central nervous system disease
  • Patients with a history of another primary cancer within 5 years
  • Prior chemotherapy for metastatic colorectal cancer
  • Prior full field radiotherapy within 4 weeks or limited field radiotherapy within 2 weeks before entry to study
  • Major surgery within 4 weeks or minor surgery within 2 weeks before entry to study
  • Investigational drugs within 4 weeks before entry to study
  • Prior therapy with anti-VEGF agents
  • Any prior therapy with oxaliplatin or allergy to platinum-containing drugs
  • Peripheral neuropathy with functional impairment
  • Female patients who are pregnant or breast feeding
  • Any severe or uncontrolled medical conditions which could prevent participation in study
  • Patients who are taking Coumadin

Other protocol-defined inclusion / exclusion criteria may apply

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00056459

  Hide Study Locations
Locations
United States, Alabama
Alabama Hematology/Oncology
Birmingham, Alabama, United States, 35243
United States, Arizona
Arizona Cancer Center
Tucson, Arizona, United States, 85724
Palo Verde Hematology & Oncology
Glendale, Arizona, United States, 85304
United States, Arkansas
Highlands Oncology Group
Springdale, Arkansas, United States, 72764
Northeast Arkansas Clinic
Jonesboro, Arkansas, United States, 72401
United States, California
Ronald Yanagiharaa, M.D.
Gilroy, California, United States, 95020
Cancer Institute Medical Group
Los Angeles, California, United States, 90025
Providence St. Joseph Medical Center
Burbank, California, United States, 91505
Pacific Shores Medical Group
Long Beach, California, United States, 90813
UCLA School of Medicine
Los Angeles, California, United States, 90095
Compassionate Cancer Care Medical Group, Inc
Fountain Valley, California, United States, 92708
The Lucy Curci Cancer Center
Rancho Mirage, California, United States, 92270
Santa Clara Valley Medical Center
San Jose, California, United States, 95128
San Diego Cancer Center Medical Group
Vista, California, United States, 92083
Synergy Hematology-Oncology Medical Associates
Los Angeles, California, United States, 90057
Comprehensive Blood and Cancer Center
Bakersfield, California, United States, 93309
California Oncology of the Central Valley
Fresno, California, United States, 93710
Virginia K. Crosson Cancer Center
Fullerton, California, United States, 92835
Wilshire Oncology Medical Group
Pomona, California, United States, 91767
Eddie Hong-Lung Hu, M.D.
Monterey Park, California, United States, 91754
North Valley Hematology/Oncology Medical Group
Northridge, California, United States, 91328
Ventura County Hematology-Oncology Specialists
Oxnard, California, United States, 93030
Sierra View District Hospital
Porterville, California, United States, 93257
Cancer Care Associates Medical Group, Inc.
Redondo Beach, California, United States, 90277
Santa Barbara Hematology Oncology Medical Group, Inc.
Santa Barbara, California, United States, 93105
Sansum Santa Barbara Foundation Medical Clinic
Santa Barbara, California, United States, 93105
USC/Norris Comprehensive Cancer Care Center
Los Angeles, California, United States, 90033
Glendale Adventist Medical Center Cancer Center
Glendale, California, United States, 91206
Pacific Hematology Oncology Associates
San Francisco, California, United States, 94904
United States, Colorado
Jennifer Caskey, M.D.
Wheat Ridge, Colorado, United States, 08833
Colorado Cancer Research Program
Denver, Colorado, United States, 80224
United States, Connecticut
Davis, Posteraro and Wasser, MD's, LLP
Manchester, Connecticut, United States, 06040
Connecticut Oncology Group
Middletown, Connecticut, United States, 06457
United States, Delaware
Medical Oncology Hematology Consultants
Newark, Delaware, United States, 19808
United States, District of Columbia
Washington Oncology-Hematology Center
Washington, District of Columbia, United States, 20016
George Washington University Medical Center
Washington, District of Columbia, United States, 20037
United States, Florida
Innovative Medical Research of South Florida
Miami Shores, Florida, United States, 33138
Lakeland Regional Cancer Center
Lakeland, Florida, United States, 33803
Florida Oncology Associates
Jacksonville, Florida, United States, 32204
Hematology Oncology Associates of Treasure
Port St. Lucie, Florida, United States, 34952
Florida Cancer Specialists
Ft. Myers, Florida, United States, 33901
Oncology Hematology Group of South Florida
Miami, Florida, United States, 33176
Florida Medical Clinic, PA
Zephyrhills, Florida, United States, 33542
Boca Raton Comprehensive Cancer Center
Boca Raton, Florida, United States, 33486
Memorial Healthcare System
Hollywood, Florida, United States, 33021
United States, Georgia
Peachtree Hematology and Oncology
Atlanta, Georgia, United States, 40202
Coastal Hematology & Oncology
Savannah, Georgia, United States, 31406
United States, Idaho
North Idaho Cancer Center
Couer d'Alene, Idaho, United States, 83814
United States, Illinois
Northshore Cancer Research Association
Skokie, Illinois, United States, 60076
Midwest Cancer Research Group
Skokie, Illinois, United States, 60077
Shelby D. Rifkin, M.D.
Arlington Heights, Illinois, United States, 60004
Oncology Hematology Associates of Central Illinois, PC
Peoria, Illinois, United States, 61602
Monroe Medical Associates
Harvey, Illinois, United States, 60426
United States, Indiana
Associated Physicians & Surgeons Clinic, L.L.C.
Terre Haute, Indiana, United States, 47804
Hematology-Oncology of Indiana, PC
Indianapolis, Indiana, United States, 46260
United States, Kentucky
Norton Healthcare Pavilion
Louisville, Kentucky, United States, 40202
Vijay Raghavan, M.D.
Louisville, Kentucky, United States, 40215
Markey Clinical Oncology Research Program
Lexington, Kentucky, United States, 40536-0098
United States, Louisiana
LSU Medical Center
New Orleans, Louisiana, United States, 70112
Tulane University Health Sciences Center
New Orleans, Louisiana, United States, 70112
LSU Health Sciences Center
Shreveport, Louisiana, United States, 71130-3932
Louisiana Oncology Associates
Lafayette, Louisiana, United States, 70506
United States, Maine
Maine Center for Cancer Medicine & Blood Disorders
Scarborough, Maine, United States, 04074
United States, Maryland
St. Agnes Healthcare, Inc.
Baltimore, Maryland, United States, 21229-5299
Kaiser Permanente
Rockville, Maryland, United States, 20850
United States, Michigan
Spectrum Health -- Cook Research Dept.
Grand Rapids, Michigan, United States, 49503
Josephine Ford Cancer Center
Detroit, Michigan, United States, 48202
Hematology and Oncology Assoc. of Southern Mississippi
Jackson, Michigan, United States, 48201
Providence Cancer Center
Southfield, Michigan, United States, 48075
Genesys Hurley Cancer Institute
Flint, Michigan, United States, 48503
Oncology Care Associates, PLLC
St. Joseph, Michigan, United States, 49085
St. Joseph Mercy Hospital
Ann Arbor, Michigan, United States, 48106-0995
United States, Minnesota
SMDC Health System
Duluth, Minnesota, United States, 55805
Minnesota CGOP
Minneapolis, Minnesota, United States, 55407
Metro Minnesota CCOP
St. Louis Park, Minnesota, United States, 55426
University of Minnesota Cancer Center
Minneapolis, Minnesota, United States, 55455
United States, Missouri
Heartland Hematology/Oncology Associates, Inc.
Kansas City, Missouri, United States, 64118
Kansas City Oncology and Hematology Group
Kansas City, Missouri, United States, 64131
Saint Louis University
St. Louis, Missouri, United States, 63110
Missouri Cancer Care, PC
St. Charles, Missouri, United States, 63301
Washington University School of Medicine
St. Louis, Missouri, United States, 63110
Missouri Baptist Cancer Center
St. Louis, Missouri, United States, 63131
Arch Medical Services Incorporated
St. Louis, Missouri, United States, 63141
United States, Montana
North Central Montana Professional Building
Great Falls, Montana, United States, 59405
Montana Cancer Specialists
Missoula, Montana, United States, 59807-7877
United States, Nebraska
The Methodist Cancer Center
Omaha, Nebraska, United States, 68114
United States, Nevada
Nevada Cancer Center
Las Vegas, Nevada, United States, 89109
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States, 89109
United States, New Jersey
Hematology-Oncology Associates of New Jersey
Morristown, New Jersey, United States, 07960
The Center for Cancer and Hematologic Disease
Cherry Hill, New Jersey, United States, 08003
St. Barnabas Cancer Center
Livingston, New Jersey, United States, 07039
Cooper Cancer Institute
Voorhees, New Jersey, United States, 08043
Southern Oncology and Hematology Associates
Vineland, New Jersey, United States, 08360
United States, New Mexico
New Mexico Cancer Care
Santa Fe, New Mexico, United States, 87505
United States, New York
New York Oncology Hematology
Latham, New York, United States, 12110
Cancer Research of Long Island
Great Neck, New York, United States, 11023
Roswell Park Cancer Institute
Buffalo, New York, United States, 14263
Broome Oncology
Johnson City, New York, United States, 13790
Pluta Cancer Center
Rochester, New York, United States, 14623
North Shore University Hospital
Manhasset, New York, United States, 11030
Cancer Center at Nyack Hospital
Nyack, New York, United States, 10960
CR Wood Cancer Center
Glen Falls, New York, United States, 12801
United States, North Carolina
Carolina Medical Center
Charlotte, North Carolina, United States, 28203
United States, North Dakota
Mid-Dakota Clinic PC
Bismarck, North Dakota, United States, 58501
United States, Ohio
Nashat Gabrail, M.D.
Canton, Ohio, United States, 44718
Hematology Oncology Consultants, Inc.
Columbus, Ohio, United States, 43235
Meridia Cancer Institute
Mayfield Heights, Ohio, United States, 44124
Mid Ohio Oncology/Hematology, Inc.
Columbus, Ohio, United States, 43213
United States, Oklahoma
Cancer Care Associates
Oklahoma City, Oklahoma, United States, 73112
Cancer Care Associates
Tulsa, Oklahoma, United States, 74136-1929
United States, Oregon
Kaiser Permanente Oncology Hematology
Portland, Oregon, United States, 97227
United States, Pennsylvania
Allegheny Cancer Center
Pittsburgh, Pennsylvania, United States, 15212-4772
University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania, United States, 19104
Hershey Medical Center
Hershey, Pennsylvania, United States, 17033
Monogahela Valley Hospital
Monogahela, Pennsylvania, United States, 15063
United States, South Carolina
South Carolina Oncology Associates
Columbia, South Carolina, United States, 29201
Cancer Center of the Carolinas
Greenville, South Carolina, United States, 29615
Charleston Cancer Center
Charleston, South Carolina, United States, 29406
Charleston Hematology Oncology
Charleston, South Carolina, United States, 29403
Spartanburg Regional Medical Center
Spartanburg, South Carolina, United States, 29303
United States, Tennessee
University of Tennessee Cancer Institute
Memphis, Tennessee, United States, 38104
Sarah Cannon Cancer Center
Nashville, Tennessee, United States, 37203
The Jones Clinic
Germantown, Tennessee, United States, 38138
Baptist Regional Cancer Center
Knoxville, Tennessee, United States, 37920
United States, Texas
M.D. Anderson Cancer Center
Houston, Texas, United States, 77030
Southwest Regional Cancer Center
Austin, Texas, United States, 78705
H. Alejandro Preti, MD, PA
Houston, Texas, United States, 77030
Center for Oncology Research & Treatment, PA
Dallas, Texas, United States, 75230
Scott & White Hospital
Temple, Texas, United States, 76508
Oncology Consultants
Houston, Texas, United States, 77024
Dr. Lee C. Drinkard
Irving, Texas, United States, 75038
Corpus Christi Cancer Center
Corpus Christi, Texas, United States, 78412
United States, Utah
Utah Cancer Specialists
Salt Lake City, Utah, United States, 84124
North Utah Associates
Ogden, Utah, United States, 84403-3105
United States, Vermont
Southwestern Vermont Health Care
Bennington, Vermont, United States, 05201
United States, Virginia
Northern Virginia Oncology Group
Fairfax, Virginia, United States, 22031
Danville Hematology and Oncology, Inc.
Danville, Virginia, United States, 24541
Cancer Treatment Centers of America
Portsmouth, Virginia, United States, 23704
Virginia Cancer Institute
Richmond, Virginia, United States, 23230
Virginia Oncology Associates
Norfolk, Virginia, United States, 23502
United States, Washington
Cascade Cancer Center
Kirkland, Washington, United States, 98034
Western Washington Medical Group
Everett, Washington, United States, 982901
Western Washington Medical Group
Everett, Washington, United States, 98201
United States, Wisconsin
UW Health -- University of Wisconsin Comp
Madison, Wisconsin, United States, 53792
Waukesha Memorial Hospital
Waukesha, Wisconsin, United States, 53188
Australia
Garran, Australia, ACT 2605
Woolloongabba, Australia, QLD 4102
Wollongong, Australia, NSW 2500
Adelaide, Australia, SA 5000
Nedlands, Australia, WS 6009
Belgium
Bruxelles, Belgium, 1200
Wilrijk, Belgium, 2610
Antwerpen, Belgium, 2020
Anderlecht, Belgium, 1070
Gent, Belgium, 9000
Brazil
Sao Paulo, Brazil, 05651-901
Porto Alegre Rs, Brazil, 90020-090
Sao Paulo, Brazil, S01308-050
Porto Alegre, Brazil, CeP 90 610-000
Salvador, Brazil, BA 41825-010
Sao Paulo, Brazil, S01232-910
Canada, Ontario
Toronto, Ontario, Canada
Hamilton, Ontario, Canada
Novartis Investigative Site
Toronto, Ontario, Canada, M5G 2M9
Canada, Quebec
Sainte-Foy, Quebec, Canada
Czech Republic
Praha 2, Czech Republic, 128 08
Brno, Czech Republic, 656 53
Praha 5, Czech Republic, 150 18
France
Marseille Cedex 05, France, 13385
Strasbourg, France, 6700
Marseille Cedex 9, France, 13273
Germany
Essen, Germany, 45122
Kiel, Germany, 24116
Hannover, Germany, 30625
Berlin, Germany, 14195
Frankfurt, Germany, 60488
Eschweiler, Germany, 52249
Erlangen, Germany, 91054
Leipzig, Germany, 4103
Berlin, Germany, 13353
Augsburg, Germany, 86150
Dessau, Germany, 6822
Heidelberg, Germany, 69115
Magdeburg, Germany, 39002
Köln, Germany, 50677
Hungary
Gyor, Hungary, H-9002
Budapest, Hungary, H-1097
Budapest, Hungary, H-1032
Szeged, Hungary, H-6725
Italy
Roma, Italy, 144
Roma, Italy, 135
Modena, Italy, 41100
Genova, Italy, 16132
Rozzano, Italy, 20089
Torino, Italy, 10126
Forli, Italy, 47100
Milano, Italy, 20162
Netherlands
Ga Utrecht, Netherlands, 3508
New Zealand
Novartis Investigative Site
Hamilton, New Zealand
Palmerston North, New Zealand
Portugal
Coimbra, Portugal, 3000-076
Slovakia
Novartis Investigative Site
Kosice, Slovakia, 041 90
Novartis Investigative Site
Bratislava, Slovakia, 81250
Novartis Investigative Site
Zilina, Slovakia, 012 07
Novartis Investigative Site
Bratislava, Slovakia, 833 10
Spain
Alicante, Spain, 3202
Madrid, Spain, 28035
Madrid, Spain, 28033
Malaga, Spain, 29010
Zaragoza, Spain, 50009
Madrid, Spain, 28041
Sweden
Stockholm, Sweden, SE-118 83
Switzerland
Bern, Switzerland, 3010
Zurich, Switzerland, 8027
Basel, Switzerland, 4031
Thun, Switzerland, 3600
Zürich, Switzerland, 8091
Taiwan
Taipei, Taiwan
Tao-Yuan, Taiwan
Tainan, Taiwan
United Kingdom
Leicester, United Kingdom, LE1 5WW
Belfast, United Kingdom, BT9 7AB
Oxford, United Kingdom, OX3 7LJ
Sponsors and Collaborators
Novartis
Bayer
Investigators
Study Chair: Novartis / Schering AG, Germany Novartis / Schering AG, Germany
  More Information

No publications provided

Responsible Party: Novartis ( External Affairs )
Study ID Numbers: CPTK787 0135/306241, CONFIRM 1
Study First Received: March 13, 2003
Last Updated: November 18, 2009
ClinicalTrials.gov Identifier: NCT00056459     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by Novartis:
Colorectal Cancer
PTK787
Vatalanib
VEGF inhibitor
Oxaliplatin
Angiogenesis
Rectal Cancer
Colon Cancer
Colorectal Carcinoma
Colorectal Tumor

Additional relevant MeSH terms:
Molecular Mechanisms of Pharmacological Action
Gastrointestinal Diseases
Rectal Neoplasms
Antineoplastic Agents
Colonic Diseases
Physiological Effects of Drugs
Leucovorin
Rectal Diseases
Protein Kinase Inhibitors
Vatalanib
Oxaliplatin
Neoplasms by Site
Vitamins
Therapeutic Uses
Micronutrients
Digestive System Neoplasms
Vitamin B Complex
Growth Substances
Enzyme Inhibitors
Intestinal Diseases
Intestinal Neoplasms
Pharmacologic Actions
Neoplasms
Digestive System Diseases
Gastrointestinal Neoplasms
Colonic Neoplasms
Colorectal Neoplasms

ClinicalTrials.gov processed this record on November 27, 2009